Basic/Clinical Science Session
Leading Edge of Therapeutic Development in Cystic Kidney Diseases
November 06, 2025 | 02:00 PM - 04:00 PM
Location: Room 310A, Convention Center
Session Description
Advanced mechanistic understanding of rare genetic cystic kidney diseases has furthered therapeutic target identification and progress toward clinical trials. This session highlights diverse treatment approaches and opportunities and challenges in advancement to clinical trials.
Learning Objective(s)
- Explain drug repurposing
- Compare and contrast therapeutic target identification across diverse rare kidney diseases
- Describe cellular drug screening paradigms
Learning Pathway(s)
- Genetic Diseases and Development
Moderators
Presentations
- Therapeutic Approaches for Nephronophthisis and Renal Ciliopathies
02:00 PM - 02:30 PM
- Promising Drug Targets and Prospects for Clinical Trials in Renal Ciliopathies
02:30 PM - 03:00 PM
- Temporal Transcriptomics in PKD Models to Identify Drug Targets
03:00 PM - 03:30 PM
- siRNA Therapy Using Nanoparticles to Treat PKD
03:30 PM - 04:00 PM